Form 4 for VRCA Verrica Pharmaceuticals Inc.
Accepted 2022-07-11 00:00:00 ET · period of report 2022-07-11 · accession 0001209191-22-041835 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-11 | 2022-07-11 | VRCA | Hayes Christopher G. | CLO | P - Purchase | $3.40 | +7,500 | 15.7K | +91% | +$25.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-11 | P | A | 7,500 | $3.40 | 15,714 | D | — | — |